Ignacio Casarini
Impact in
-
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 9
- Lung Cancer Diagnosis and Treatment 4
- Gastric Cancer Management and Outcomes 2
- Oncology 8
- Lung Cancer Research Studies 4
- Cancer Immunotherapy and Biomarkers 4
- HER2/EGFR in Cancer Research 1
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Shun Lü (6 shared papers)Mustafa Özgüroğlu (5 shared papers)Manuel Cobo (6 shared papers)Terufumi Kato (4 shared papers)Suresh S. Ramalingam (4 shared papers)Toon van der Gronde (3 shared papers)Matilde Saggese (2 shared papers)Rachel Hodge (1 shared paper)
In The Last Decade
Ignacio Casarini
9 papers receiving 76 citations
Peers
Comparison fields: 5 of 17
- Oncology 55
- Pulmonary and Respiratory Medicine 61
- Cancer Research 7
- Immunology 9
- Occupational Therapy 1
Countries citing papers authored by Ignacio Casarini
This map shows the geographic impact of Ignacio Casarini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Casarini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Casarini more than expected).
Fields of papers citing papers by Ignacio Casarini
This network shows the impact of papers produced by Ignacio Casarini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Casarini. The network helps show where Ignacio Casarini may publish in the future.
Co-authors
The 25 scholars most cited alongside Ignacio Casarini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 43 | |
| 2 | 2023 | 9 | |
| 3 | 2023 | 6 | |
| 4 | 2024 | 5 | |
| 5 | 2025 | 4 | |
| 6 | 2025 | 3 | |
| 7 | 2023 | 3 | |
| 8 | 2024 | 3 | |
| 9 | 2020 | 2 | |
| 10 | 2025 | 0 |
About Ignacio Casarini
Ignacio Casarini is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Gastroenterology and Cancer Research, having authored 10 papers that have together received 78 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (4 papers), Lung Cancer Research Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Gastric Cancer Management and Outcomes (2 papers), HER2/EGFR in Cancer Research (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Gastrointestinal Tumor Research and Treatment (1 paper). The work is most often cited by research in Oncology (55 citations), Pulmonary and Respiratory Medicine (61 citations), Cancer Research (7 citations), Immunology (9 citations) and Occupational Therapy (1 citation). Ignacio Casarini has collaborated with scholars based in Japan, Spain and China. Frequent co-authors include Shun Lü, Mustafa Özgüroğlu, Manuel Cobo, Terufumi Kato, Suresh S. Ramalingam, Toon van der Gronde, Matilde Saggese, Rachel Hodge, Fiona Hegi‐Johnson and Antonio Calles. Their work appears in journals such as Journal of Thoracic Oncology, Annals of Oncology, Journal of Clinical Oncology, Clinical Lung Cancer and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.